 | • レポートコード：QYR2104Z4561 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、製薬契約開発＆製造のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品製造サービス、生物製剤製造サービス、医薬品開発サービス）、用途別市場規模（大手製薬会社、中小製薬会社、ジェネリック製薬会社、CRO）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・製薬契約開発＆製造の市場動向 ・企業の競争状況、市場シェア ・製薬契約開発＆製造の種類別市場規模（医薬品製造サービス、生物製剤製造サービス、医薬品開発サービス） ・製薬契約開発＆製造の用途別市場規模（大手製薬会社、中小製薬会社、ジェネリック製薬会社、CRO） ・製薬契約開発＆製造の北米市場規模2016-2027（アメリカ、カナダ） ・製薬契約開発＆製造のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・製薬契約開発＆製造のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・製薬契約開発＆製造の中南米市場規模2016-2027（メキシコ、ブラジル） ・製薬契約開発＆製造の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific Inc.、Catalent, Inc.、Lonza Group Ltd、Recipharm AB、Vetter Pharma International GMBH、FAMAR Health Care Services、AbbVie Inc.、Aenova Group、Consort Medical plc、Almac Group、Siegfried Holding AG、Boehringer Ingelheim International GmbH、Evonik Industries AG） ・結論 |
Market Analysis and Insights: Global Pharmaceutical Contract Development and Manufacturing Market
The global Pharmaceutical Contract Development and Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Contract Development and Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Contract Development and Manufacturing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Contract Development and Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Contract Development and Manufacturing market.
Global Pharmaceutical Contract Development and Manufacturing Scope and Market Size
Pharmaceutical Contract Development and Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Contract Development and Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Segment by Application
Big Pharma
Small Pharma
Generic Pharma
CRO
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific Inc.
Catalent, Inc.
Lonza Group Ltd
Recipharm AB
Vetter Pharma International GMBH
FAMAR Health Care Services
AbbVie Inc.
Aenova Group
Consort Medical plc
Recipharm AB
Vetter Pharma International GMBH
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmaceutical Manufacturing Services
1.2.3 Biologics Manufacturing Services
1.2.4 Drug Development Services
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Big Pharma
1.3.3 Small Pharma
1.3.4 Generic Pharma
1.3.5 CRO
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Development and Manufacturing Market Perspective (2016-2027)
2.2 Pharmaceutical Contract Development and Manufacturing Growth Trends by Regions
2.2.1 Pharmaceutical Contract Development and Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical Contract Development and Manufacturing Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical Contract Development and Manufacturing Industry Dynamic
2.3.1 Pharmaceutical Contract Development and Manufacturing Market Trends
2.3.2 Pharmaceutical Contract Development and Manufacturing Market Drivers
2.3.3 Pharmaceutical Contract Development and Manufacturing Market Challenges
2.3.4 Pharmaceutical Contract Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
3.4 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Revenue in 2020
3.5 Pharmaceutical Contract Development and Manufacturing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Type
4.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2022-2027)
5 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Application
5.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2016-2027)
6.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type
6.2.1 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2027)
6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application
6.3.1 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2027)
6.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country
6.4.1 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2016-2027)
7.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type
7.2.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application
7.3.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country
7.4.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Size (2016-2027)
9.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type
9.2.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application
9.3.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country
9.4.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Catalent, Inc.
11.2.1 Catalent, Inc. Company Details
11.2.2 Catalent, Inc. Business Overview
11.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.2.5 Catalent, Inc. Recent Development
11.3 Lonza Group Ltd
11.3.1 Lonza Group Ltd Company Details
11.3.2 Lonza Group Ltd Business Overview
11.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Introduction
11.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.3.5 Lonza Group Ltd Recent Development
11.4 Recipharm AB
11.4.1 Recipharm AB Company Details
11.4.2 Recipharm AB Business Overview
11.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Introduction
11.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.4.5 Recipharm AB Recent Development
11.5 Vetter Pharma International GMBH
11.5.1 Vetter Pharma International GMBH Company Details
11.5.2 Vetter Pharma International GMBH Business Overview
11.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Introduction
11.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.5.5 Vetter Pharma International GMBH Recent Development
11.6 FAMAR Health Care Services
11.6.1 FAMAR Health Care Services Company Details
11.6.2 FAMAR Health Care Services Business Overview
11.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Introduction
11.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.6.5 FAMAR Health Care Services Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.7.5 AbbVie Inc. Recent Development
11.8 Aenova Group
11.8.1 Aenova Group Company Details
11.8.2 Aenova Group Business Overview
11.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Introduction
11.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.8.5 Aenova Group Recent Development
11.9 Consort Medical plc
11.9.1 Consort Medical plc Company Details
11.9.2 Consort Medical plc Business Overview
11.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Introduction
11.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.9.5 Consort Medical plc Recent Development
11.10 Almac Group
11.10.1 Almac Group Company Details
11.10.2 Almac Group Business Overview
11.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Introduction
11.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.10.5 Almac Group Recent Development
11.11 Siegfried Holding AG
11.11.1 Siegfried Holding AG Company Details
11.11.2 Siegfried Holding AG Business Overview
11.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Introduction
11.11.4 Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.11.5 Siegfried Holding AG Recent Development
11.12 Boehringer Ingelheim International GmbH
11.12.1 Boehringer Ingelheim International GmbH Company Details
11.12.2 Boehringer Ingelheim International GmbH Business Overview
11.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Introduction
11.12.4 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.12.5 Boehringer Ingelheim International GmbH Recent Development
11.13 Evonik Industries AG
11.13.1 Evonik Industries AG Company Details
11.13.2 Evonik Industries AG Business Overview
11.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Introduction
11.13.4 Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
11.13.5 Evonik Industries AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmaceutical Manufacturing Services
Table 3. Key Players of Biologics Manufacturing Services
Table 4. Key Players of Drug Development Services
Table 5. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2016-2021)
Table 9. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2022-2027)
Table 11. Pharmaceutical Contract Development and Manufacturing Market Trends
Table 12. Pharmaceutical Contract Development and Manufacturing Market Drivers
Table 13. Pharmaceutical Contract Development and Manufacturing Market Challenges
Table 14. Pharmaceutical Contract Development and Manufacturing Market Restraints
Table 15. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players (2016-2021)
Table 17. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2020)
Table 18. Ranking of Global Top Pharmaceutical Contract Development and Manufacturing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
Table 22. Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2016-2021)
Table 26. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pharmaceutical Contract Development and Manufacturing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2016-2021)
Table 30. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific Inc. Company Details
Table 63. Thermo Fisher Scientific Inc. Business Overview
Table 64. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product
Table 65. Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific Inc. Recent Development
Table 67. Catalent, Inc. Company Details
Table 68. Catalent, Inc. Business Overview
Table 69. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product
Table 70. Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 71. Catalent, Inc. Recent Development
Table 72. Lonza Group Ltd Company Details
Table 73. Lonza Group Ltd Business Overview
Table 74. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product
Table 75. Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 76. Lonza Group Ltd Recent Development
Table 77. Recipharm AB Company Details
Table 78. Recipharm AB Business Overview
Table 79. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product
Table 80. Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 81. Recipharm AB Recent Development
Table 82. Vetter Pharma International GMBH Company Details
Table 83. Vetter Pharma International GMBH Business Overview
Table 84. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product
Table 85. Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 86. Vetter Pharma International GMBH Recent Development
Table 87. FAMAR Health Care Services Company Details
Table 88. FAMAR Health Care Services Business Overview
Table 89. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product
Table 90. FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 91. FAMAR Health Care Services Recent Development
Table 92. AbbVie Inc. Company Details
Table 93. AbbVie Inc. Business Overview
Table 94. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product
Table 95. AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 96. AbbVie Inc. Recent Development
Table 97. Aenova Group Company Details
Table 98. Aenova Group Business Overview
Table 99. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 100. Aenova Group Recent Development
Table 101. Consort Medical plc Company Details
Table 102. Consort Medical plc Business Overview
Table 103. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product
Table 104. Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 105. Consort Medical plc Recent Development
Table 106. Almac Group Company Details
Table 107. Almac Group Business Overview
Table 108. Almac Group Pharmaceutical Contract Development and Manufacturing Product
Table 109. Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 110. Almac Group Recent Development
Table 111. Siegfried Holding AG Company Details
Table 112. Siegfried Holding AG Business Overview
Table 113. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product
Table 114. Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 115. Siegfried Holding AG Recent Development
Table 116. Boehringer Ingelheim International GmbH Company Details
Table 117. Boehringer Ingelheim International GmbH Business Overview
Table 118. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product
Table 119. Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 120. Boehringer Ingelheim International GmbH Recent Development
Table 121. Evonik Industries AG Company Details
Table 122. Evonik Industries AG Business Overview
Table 123. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product
Table 124. Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2016-2021) & (US$ Million)
Table 125. Evonik Industries AG Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Contract Development and Manufacturing Market Share by Type: 2020 VS 2027
Figure 2. Pharmaceutical Manufacturing Services Features
Figure 3. Biologics Manufacturing Services Features
Figure 4. Drug Development Services Features
Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2020 VS 2027
Figure 6. Big Pharma Case Studies
Figure 7. Small Pharma Case Studies
Figure 8. Generic Pharma Case Studies
Figure 9. CRO Case Studies
Figure 10. Pharmaceutical Contract Development and Manufacturing Report Years Considered
Figure 11. Global Pharmaceutical Contract Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pharmaceutical Contract Development and Manufacturing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions: 2020 VS 2027
Figure 14. Global Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2022-2027)
Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players in 2020
Figure 16. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2020
Figure 18. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2016-2021)
Figure 19. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2022-2027)
Figure 20. North America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2027)
Figure 22. North America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2027)
Figure 23. North America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2016-2027)
Figure 24. United States Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2027)
Figure 28. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2027)
Figure 29. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Country (2016-2027)
Figure 30. Germany Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Share by Region (2016-2027)
Figure 40. China Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2027)
Figure 48. Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2027)
Figure 49. Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2016-2027)
Figure 50. Mexico Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Share by Country (2016-2027)
Figure 56. Turkey Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 60. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 61. Lonza Group Ltd Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 62. Recipharm AB Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 63. Vetter Pharma International GMBH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 64. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 65. AbbVie Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 66. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 67. Consort Medical plc Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 68. Almac Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 69. Siegfried Holding AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 70. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 71. Evonik Industries AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のソフトジェルカプセルにおける医薬品受託製造サービス市場規模・現状・予測（2021年-2027年） The company supply Softgel Capsule contract pharmaceutical manufacturing services Market Analysis and Insights: Global Contract Pharmaceutical Manufacturing Services in Softgel Capsule Market The global Contract Pharmaceutical Manufacturing Services in Softgel Capsule market size is projected to rea…- 世界のソフトジェルカプセルにおける医薬品受託製造サービス市場規模・現状・予測（2021年-2027年） The company supply Softgel Capsule contract pharmaceutical manufacturing services Market Analysis and Insights: Global Contract Pharmaceutical Manufacturing Services in Softgel Capsule Market The global Contract Pharmaceutical Manufacturing Services in Softgel Capsule market size is projected to rea…
- 世界の製薬契約製造＆契約市場規模・現状・予測（2021年-2027年） Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing. North America is the largest consumption place, with a consumption mark…
- 製薬用契約開発・製造の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Pharmaceutical Contract Development and Manufacturing from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players,…
- 世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing(BCMO) Market The global Biopharmaceutical Contract Manufacturing(BCMO) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accura…